glp 1 liver fibrosis Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Pioglitazone with SGLT2 inhibitors or
Description
The physicians role is to evaluate whether the medication makes sense and how to use it safely
Ali: Other factors can include underlying medical conditions or the patient not using the medications exactly as prescribed
That finding is accurate
Understanding why GLP-1 therapy may not be effective for you is the first step towards finding the right solution, whether that involves optimising your current treatment, switching medications, or exploring alternative approaches tailored to your individual circumstances
Empagliflozin FDA product information (2023)
This means adopting and sticking to significant lifestyle changes
